Recent advances in research on granulocyte colony-stimulating factor--review.
- Author:
Jing-Min YU
1
;
Zhi-Yun MENG
;
Gui-Fang DOU
Author Information
1. Institute of Transfusion Medicine, Academy of Military Medical Sciences, Beijing 100850, China.
- Publication Type:Journal Article
- MeSH:
Granulocyte Colony-Stimulating Factor;
pharmacokinetics;
pharmacology;
therapeutic use;
Hematopoiesis;
drug effects;
Humans
- From:
Journal of Experimental Hematology
2008;16(2):452-456
- CountryChina
- Language:Chinese
-
Abstract:
Granulocyte colony-stimulating factor (G-CSF) is a kind of hematopoietic growth factor which is produced by monocytes, fibroblasts and endothelial cells. G-CSF acts on neutrophilic progenitor cells by binding to specific cell surface receptors, thereby stimulates proliferation, differentiation, commitment, and selected end-cell functional activation including enhanced phagocytic ability, priming of the cellular metabolism associated with respiratory burst, antibody dependent killing and the increased expression of some functions associated with cell surface antigens. G-CSF is effective and safe for treatment of neutropenia. In this paper, structure of G-CSF and its mechanism, recent status of research on G-CSF, pharmacokinetics, clinical application, adverse effects and prospect of G-CSF are mainly reviewed.
